BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen JF, Fu XT, Gao Z, Shi YH, Tang Z, Liu WR, Zhang X, Gao Q, Ding GY, Song K, Wang XY, Zhou J, Fan J, Ding ZB. Laparoscopic vs. Open Repeat Hepatectomy for Recurrent Liver Tumors: A Propensity Score-Matched Study and Meta-Analysis. Front Oncol 2021;11:646737. [PMID: 33968747 DOI: 10.3389/fonc.2021.646737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Alvikas J, Lo W, Tohme S, Geller DA. Outcomes and Patient Selection in Laparoscopic vs. Open Liver Resection for HCC and Colorectal Cancer Liver Metastasis. Cancers (Basel) 2023;15. [PMID: 36831521 DOI: 10.3390/cancers15041179] [Reference Citation Analysis]
2 Lv TR, Hu HJ, Ma WJ, Hu YF, Dai YS, Li FY. The role of laparoscopic surgery in the surgical management of recurrent liver malignancies: A systematic review and meta-analysis. Front Surg 2022;9:1042458. [PMID: 36684258 DOI: 10.3389/fsurg.2022.1042458] [Reference Citation Analysis]
3 Chang DM, Chen YF, Chen HY, Chiu CC, Lee KT, Wang JJ, Sun DP, Lee HH, Shiu YT, Chen IT, Shi HY. Inverse Probability of Treatment Weighting in 5-Year Quality-of-Life Comparison among Three Surgical Procedures for Hepatocellular Carcinoma. Cancers (Basel) 2022;15. [PMID: 36612245 DOI: 10.3390/cancers15010252] [Reference Citation Analysis]
4 Xi C, Zhu M, Ji T, Tan Y, Zhuang L, Yuan Z, Zhang Z, Xu L, Liu Z, Xu X, Xue W, Ding W. A novel difficulty scoring system of laparoscopic liver resection for liver tumor. Front Oncol 2022;12:1019763. [DOI: 10.3389/fonc.2022.1019763] [Reference Citation Analysis]
5 Hao F, Li H, Li N, Li J, Wu H. Laparoscopic repeat hepatectomy versus conventional open repeat hepatectomy for recurrent hepatocellular carcinoma: A systematic review and meta-analysis. Front Oncol 2022;12:960204. [DOI: 10.3389/fonc.2022.960204] [Reference Citation Analysis]
6 Shen Y, Huang C, Zhu X, Xu M, Chen Z, Tan C, Zhou J, Fan J, Sun H. The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcinoma. Annals of Surgery Open 2022;3:e163. [DOI: 10.1097/as9.0000000000000163] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]